XML 28 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

 

6.STOCK-BASED COMPENSATION

The P. H. Glatfelter Amended and Restated Long Term Incentive Plan (the “LTIP”) provides for the issuance of Glatfelter common stock to eligible participants in the form of restricted stock units, restricted stock awards, non-qualified stock options, performance shares, incentive stock options and performance units.

Pursuant to terms of the LTIP, we have issued to eligible participants restricted stock units, performance share awards and stock only stock appreciation rights.

Restricted Stock Units (“RSU”) and Performance Share Awards (“PSAs”) Awards of RSUs and PSAs are made under our LTIP. The RSUs vest on the passage of time, generally on a graded scale over a three, four, and five-year period, or in certain instances the RSUs were issued with five year cliff vesting. PSAs are issued to members of management and vesting is based on achievement of cumulative financial performance targets covering a two year period followed by an additional one-year service period. The performance measures include a minimum, target and maximum performance level providing the grantees an opportunity to receive more or less shares than targeted depending on actual financial performance. For both RSUs and PSAs, the grant date fair value of the awards, which is equal to the closing price per common share on the date of the award, is used to determine the amount of expense to be recognized over the applicable service period. Settlement of RSUs and PSAs will be made in shares of our common stock currently held in treasury.

The following table summarizes RSU and PSA activity during periods indicated:

 

Units

2017

 

 

 

2016

 

Balance at January 1,

 

679,038

 

 

 

 

674,523

 

Granted

 

290,880

 

 

 

 

220,105

 

Forfeited

 

(90,801

)

 

 

 

(116,640

)

Shares delivered

 

 

 

 

 

(126,914

)

Balance at March 31,

 

879,117

 

 

 

 

651,074

 

 

The amount granted in 2017 and 2016 includes PSAs of 157,064 and 191,548, respectively, exclusive of reinvested dividends.

The following table sets forth aggregate RSU and PSA compensation expense for the periods indicated:

 

 

March 31

 

In thousands

2017

 

 

 

2016

 

Three months ended

$

1,039

 

 

 

$

467

 

 

Stock Only Stock Appreciation Rights (“SOSARs”) Under terms of the SOSAR, a recipient receives the right to a payment in the form of shares of common stock equal to the difference, if any, in the fair market value of one share of common stock at the time of exercising the SOSAR and the exercise price. The SOSARs vest ratably over a three year period and have a term of ten years.

The following table sets forth information related to outstanding SOSARS for the three months ended March 31;

 

 

2017

 

 

2016

 

SOSARS

Shares

 

 

 

Wtd Avg

Exercise

Price

 

 

Shares

 

 

Wtd Avg

Exercise

Price

 

Outstanding at January 1,

 

2,736,616

 

 

 

$

17.64

 

 

 

2,199,742

 

 

$

17.82

 

Granted

 

 

 

 

 

 

 

 

724,914

 

 

17.47

 

Exercised

 

(33,050

)

 

 

 

14.65

 

 

 

 

 

 

 

Canceled / forfeited

 

(17,420

)

 

 

 

18.38

 

 

 

(24,712

)

 

 

26.90

 

Outstanding at March 31,

 

2,686,146

 

 

 

$

17.67

 

 

 

2,899,944

 

 

$

17.65

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SOSAR Grants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average grant date

   fair value per share

$

-

 

 

 

 

 

 

 

$

4.04

 

 

 

 

 

Aggregate grant date

   fair value (in thousands)

$

-

 

 

 

 

 

 

 

$

2,919

 

 

 

 

 

Black-Scholes assumptions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividend yield

 

-

 

 

 

 

 

 

 

 

2.87

%

 

 

 

 

Risk free rate of return

 

-

 

 

 

 

 

 

 

 

1.34

%

 

 

 

 

Volatility

 

-

 

 

 

 

 

 

 

 

32.01

%

 

 

 

 

Expected life

-

 

 

 

 

 

 

 

6 yrs

 

 

 

 

 

 

The following table sets forth SOSAR compensation expense for the periods indicated:

 

 

March 31

 

In thousands

2017

 

 

 

2016

 

Three months ended

$

609

 

 

 

$

732